Your browser doesn't support javascript.
loading
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).
Lambert-Niclot, S; Grude, M; Chaix, M L; Charpentier, C; Reigadas, S; Le Guillou-Guillemette, H; Rodallec, A; Amiel, C; Maillard, A; Dufayard, J; Mourez, T; Mirand, A; Guinard, J; Montes, B; Vallet, S; Marcelin, A G; Descamps, D; Flandre, P; Delaugerre, C; Morand-Joubert, L.
Afiliação
  • Lambert-Niclot S; Sorbonne University, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Service de Virologie, APHP, Hôpital Saint-Antoine, INSERM UPMC UMR_S, Paris, France.
  • Grude M; INSERM UPMC UMR_S, Paris, France.
  • Chaix ML; Hôpital Saint-Louis, Université Paris Diderot, INSERM, Paris, France.
  • Charpentier C; IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Laboratoire de Virologie, Hôpital Bichat, AP-HP, Paris, France.
  • Reigadas S; Hôpital Pellegrin, Centre de ressources biologiques plurithématique, CHU de Bordeaux, Bordeaux, France.
  • Le Guillou-Guillemette H; CHU Angers, Angers, France.
  • Rodallec A; CHU Hôtel Dieu, Nantes, France.
  • Amiel C; Hôpital Tenon, UPMC, CR7, Paris, France.
  • Maillard A; Hôpital Pontchaillou, Rennes, France.
  • Dufayard J; CHU Nice, Nice, France.
  • Mourez T; CHU Charles Nicolle, Rouen, France.
  • Mirand A; CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Guinard J; Hôpital La Source-CHR Orléans, Orléans, France.
  • Montes B; Hôpital Saint-Eloi, Montpellier, France.
  • Vallet S; CHRU La Cavale Blanche, Brest, France.
  • Marcelin AG; Sorbonne University, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Service de Virologie, APHP Hôpital Pitié-Salpêtrière, Paris, France.
  • Descamps D; IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, AP-HP, Laboratoire de Virologie, Hôpital Bichat, AP-HP, Paris, France.
  • Flandre P; INSERM UPMC UMR_S, Paris, France.
  • Delaugerre C; Hôpital Saint-Louis, Université Paris Diderot, INSERM, Paris, France.
  • Morand-Joubert L; Sorbonne University, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Service de Virologie, APHP, Hôpital Saint-Antoine, INSERM UPMC UMR_S, Paris, France.
J Antimicrob Chemother ; 73(8): 2147-2151, 2018 08 01.
Article em En | MEDLINE | ID: mdl-29718247
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores da Protease de HIV / Farmacorresistência Viral / Sulfato de Atazanavir Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores da Protease de HIV / Farmacorresistência Viral / Sulfato de Atazanavir Idioma: En Ano de publicação: 2018 Tipo de documento: Article